Therefore, over-expressed DLEU2L targeted miR-210-3p, reduced its biological activity and simultaneously upregulated intracellular BRCA2 level, mTOR phosphorylation was inhibited, thus decreasing the potential chemotherapy resistance of gemcitabine in PC treatment and enhancing its cytotoxic effect. This evidence concerns the gene BRCA2 and pachyonychia congenita.